Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3p5k | P5K | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3p5k | P5K | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.805 | |
| 3p79 | P79 | Mitogen-activated protein kinase 14 | / | 0.679 | |
| 3o8u | BMU | Mitogen-activated protein kinase 14 | / | 0.642 | |
| 2puu | G2G | Mitogen-activated protein kinase 14 | / | 0.604 | |
| 3uvr | 06F | Mitogen-activated protein kinase 14 | / | 0.586 | |
| 3hv7 | 1AU | Mitogen-activated protein kinase 14 | / | 0.570 | |
| 3k3j | F4C | Mitogen-activated protein kinase 14 | / | 0.558 | |
| 3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 3gi3 | B10 | Mitogen-activated protein kinase 14 | / | 0.551 | |
| 1kv1 | BMU | Mitogen-activated protein kinase 14 | / | 0.546 | |
| 3nnx | EDD | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 3wze | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.541 | |
| 1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.532 | |
| 3npc | B96 | Mitogen-activated protein kinase 9 | 2.7.11.24 | 0.527 | |
| 3kq7 | KQ7 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3e93 | 19B | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 1wbt | WBT | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 4l8m | F46 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3hv4 | L51 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 1wbv | LI3 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 3p78 | P78 | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3p7a | P7A | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3ugc | 046 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
| 2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3p7c | P7C | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3cs9 | NIL | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.458 | |
| 4u0i | 0LI | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.455 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
| 4h4r | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.442 | |
| 3vhe | 42Q | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 |